---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036378"
form_type: "8-K"
ticker: null
cik: "0001603207"
company_name: "Notable Labs, Ltd."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:36:40.784870+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Notable Labs appoints Kaile Zagger as Interim CEO and Chief Restructuring Officer

## Summary
- Kaile Zagger appointed Interim CEO and CRO, effective September 16, 2024.
- Dr. Joseph Wagner steps down as interim CEO but remains Chief Scientific Officer.
- Zagger is Managing Director at Province, LLC; services provided at $900/hour.
- Zagger has over 20 years healthcare experience, including distressed turnarounds.

## SEC filing metadata
- accession: 0001493152-24-036378
- form_type: 8-K
- cik: 0001603207
- company_name: Notable Labs, Ltd.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/0001493152-24-036378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036378
- JSON: https://secwatch.observer/filing/0001493152-24-036378.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036378.txt

## Key facts
- Executive change
  Kaile A. Zagger was appointed as Interim Chief Executive Officer and Chief Restructuring Officer at Notable Labs, Ltd..
  - Action: appointed
  - Role: Interim Chief Executive Officer and Chief Restructuring Officer
  source text: On September 16, 2024, Notable Labs, Ltd. (the “Company” or “Notable”) appointed Kaile A. Zagger as its Interim Chief Executive Officer and Chief Restructuring Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/0001493152-24-036378-index.htm
- Executive change
  Joseph Wagner changed role as Chief Scientific Officer at Notable Labs, Ltd..
  - Action: stepped down
  - Role: Chief Scientific Officer
  source text: Effective September 16, 2024, Dr. Joseph Wagner, the Company’s Chief Scientific Officer, who was also acting as Chief Executive Officer on an interim basis, stepped down from his position as interim Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/0001493152-24-036378-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.